Australia's Optiscan Imaging gains on ethical clearance for breast cancer study

Optiscan Imaging

15/07/2024 05:29

** Shares of Optiscan Imaging  OIL.AX  rise 12.82% to
A$0.22, on track for their best day since June 24, if gains hold
    ** The imaging technologies maker receives ethical clearance
for breast cancer study
    ** Co says the study will assess the clinical workflow and
real-time imaging capability of its recently unveiled InVue
precision surgery imaging platform in breast cancer
    ** Stock has doubled gains this year, as of last close

 (Reporting by Sherin Sunny in Bengaluru)
 ((sherin.sunny@thomsonreuters.com))